Insmed to Present at May 2026 Investor Conferences

Rhea-AI Summary

Insmed (NASDAQ: INSM) announced management presentations at two investor conferences in May 2026: BofA Securities 2026 Healthcare Conference in Las Vegas on May 12, 2026 at 1:40 p.m. PT, and the 2026 RBC Capital Markets Global Healthcare Conference in New York City on May 20, 2026 at 10:30 a.m. ET. Webcasts will be available via the company's investor relations website and archived for 30 days.

Argus Apr 30 session

+0.96% close to close Open Argus

Details

News Market Reaction – INSM

In the Apr 30 session, INSM gained 0.96%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines upcoming presentations at major healthcare investor conferences on May 12...

Analysis

This announcement outlines upcoming presentations at major healthcare investor conferences on May 12 and May 20, 2026, with webcasts available for 30 days. In context, INSM recently reported positive Phase 3b ARIKAYCE data and detailed its 2025 financial performance with 2026 guidance, while also disclosing a setback in the CEDAR study. Investors may focus on how management frames these mixed developments and any incremental clinical or commercial detail shared during the conference appearances.

Key Figures

BofA conference date: May 12, 2026 BofA conference time: 1:40 p.m. PT RBC conference date: May 20, 2026 +2 more

BofA conference date

May 12, 2026

BofA Securities 2026 Healthcare Conference presentation date

BofA conference time

1:40 p.m. PT

Scheduled time for INSM presentation at BofA conference

RBC conference date

May 20, 2026

RBC Capital Markets Global Healthcare Conference presentation date

RBC conference time

10:30 a.m. ET

Scheduled time for INSM presentation at RBC conference

Webcast archive period

30 days

Length of time conference webcasts will remain available

Historical Context

5 past events · Latest: Apr 23

5 events

1. Apr 23

   Earnings call scheduling

   24h Move

   -0.5%

   Set date and time for Q1 2026 results and business update call.

2. Apr 07

   Clinical trial setback

   24h Move

   -1.8%

   Phase 2b CEDAR HS study failed endpoints and HS program discontinued.

3. Mar 23

   Positive clinical data

   24h Move

   +5.9%

   Phase 3b ENCORE ARIKAYCE trial met primary and key culture endpoints.

4. Mar 05

   Equity inducement grants

   24h Move

   -4.2%

   New-hire RSUs and options granted under 2025 Inducement Plan.

5. Feb 19

   Earnings and guidance

   24h Move

   +6.5%

   Reported 2025 revenue and cash plus 2026 BRINSUPRI and ARIKAYCE guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., April 30, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:

• BofA Securities 2026 Healthcare Conference in Las Vegas on Tuesday, May 12, 2026, at 1:40 p.m. PT.
• 2026 RBC Capital Markets Global Healthcare Conference in New York City on Wednesday, May 20, 2026, at 10:30 a.m. ET.

These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X. 

Contact:

Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:
Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-may-2026-investor-conferences-302754966.html

SOURCE Insmed Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Insmed (INSM) present at the BofA Securities 2026 Healthcare Conference?

Insmed will present on May 12, 2026 at 1:40 p.m. PT. According to the company, the presentation will be webcast live and archived for 30 days on the investor relations website for on-demand viewing.

What time is Insmed's (INSM) presentation at the RBC Capital Markets Global Healthcare Conference?

Insmed's presentation is scheduled for May 20, 2026 at 10:30 a.m. ET. According to the company, the event will be webcast live and the archived webcast will remain available for 30 days after the live session.

How can investors watch the Insmed (INSM) conference webcasts?

Investors can watch live and archived webcasts on Insmed's investor relations website at www.insmed.com. According to the company, webcasts are live-streamed and archived for a 30-day period following each presentation.

Will Insmed (INSM) archive the May 2026 investor conference webcasts for later viewing?

Yes. According to the company, webcasts from both May 2026 presentations will be archived and available for 30 days after each live event on the investor relations site for investors who cannot attend live.

Which investor conferences will Insmed (INSM) attend in May 2026 and where are they located?

Insmed will attend the BofA Securities 2026 Healthcare Conference in Las Vegas and the RBC Capital Markets Global Healthcare Conference in New York City. According to the company, both events will feature live webcasts on its IR website.